Spots Global Cancer Trial Database for glatiramer acetate
Every month we try and update this database with for glatiramer acetate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Comparison of Clinical Effects of Rituximab and Glatiramer Acetate in Secondary Progressive Multiple Sclerosis Patients | NCT03315923 | Secondary Progr... | Rituximab Glatiramer Acet... | 18 Years - 55 Years | Isfahan University of Medical Sciences |